slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
309,031-309,060 of 319,975
08
The slide uses a mix of historical (A) and estimated (E) data, with specific H1 comparisons.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Market Size1 hit
09
The slide uses a combination of annual historical/forecast data and half-year comparisons to explain cost structure changes.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Financials1 hit
10
Includes a detailed income statement table with Q1, Q2, H1 2012 actuals and 2012 estimates.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Financials1 hit
11
10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · Financials1 hit
12
Includes two bar charts showing historical/projected growth and a median benchmark line.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · FinancialsLoop · Pattern Hunter1 hit
13
Taro is highlighted in blue in each chart, while peers are in grey. Medians are indicated by red dashed lines.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · FinancialsLoop · Pattern Hunter1 hit
14
Includes specific footnotes regarding adjustments for peer data (e.g., Actavis, Paddock, Flomax).10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · FinancialsLoop · Pattern Hunter1 hit
15
10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · ValuationLoop · Golden Circle1 hit
16
Includes specific financial benchmarks like P/E ratios and valuation ranges relative to Sun Pharma's offer price.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · ValuationLoop · Golden Circle1 hit
17
Includes data on price bumps, offer premiums, and transaction duration.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · ValuationLoop · Golden Circle1 hit
18
Includes sensitivity tables for WACC vs Terminal EBITDA Multiple, WACC vs Implied Perpetuity Growth Rate, and WACC vs Terminal Value as a % of Enterprise Value.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · ValuationLoop · Golden Circle1 hit
19
The chart highlights a period of multiple uplift attributed to stock price appreciation ahead of product pricing increases.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · ValuationLoop · Golden Circle1 hit
20
Includes median lines for the full peer set and a sub-segment of sub-$5bn market cap peers.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Beat · ValuationLoop · Golden Circle1 hit
21
10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank 1 hit
22
Depreciation and amortization allocated 75%:25% between COGS and SG&A per Taro management.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Loop · Cost Of Inaction1 hit
23
Includes mean and median calculations for the peer group and a sub-segment of peers under $5bn market cap.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Loop · Cost Of Inaction1 hit
24
Includes a legend for healthcare deals and footnotes regarding data sources and methodology.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Loop · Cost Of Inaction1 hit
25
Includes a legend for healthcare deals and a note about exclusions.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank Loop · Cost Of Inaction1 hit
26
Market data as of August 10, 2012. Cost of debt estimated based on current B rated high yield index.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank 1 hit
27
The slide combines a dense legal disclaimer block with a paragraph describing corporate sustainability efforts.10 IBD presentation 2012 Taro Pharmaceutical Industries Citigroup · 10-ibd-presentation-2012-taro-pharmaceutical-industries-citigroup
Deck Investment bank 1 hit
01
This appears to be the first page of a 48-page document/essay.11 laws of showrunning mean version · 11-laws-of-showrunning-mean-version
Deck Investor relations Beat · Attention1 hit
02
This appears to be a page from a manuscript or long-form document rather than a traditional slide deck.11 laws of showrunning mean version · 11-laws-of-showrunning-mean-version
Deck Investor relations Beat · Attention1 hit
03
The slide is a text-heavy narrative page discussing the economics of TV production and the role of showrunners.11 laws of showrunning mean version · 11-laws-of-showrunning-mean-version
Deck Investor relations Beat · Attention1 hit
04
This appears to be a page from a long-form document or essay rather than a traditional presentation slide.11 laws of showrunning mean version · 11-laws-of-showrunning-mean-version
Deck Investor relations Beat · Attention1 hit
05
The text uses an extended metaphor comparing TV production to a retail supply chain.11 laws of showrunning mean version · 11-laws-of-showrunning-mean-version
Deck Investor relations Beat · Attention1 hit
06
This appears to be a page from a book or a long-form manifesto rather than a traditional slide deck.11 laws of showrunning mean version · 11-laws-of-showrunning-mean-version
Deck Investor relations Beat · Need1 hit
07
The slide is a text-heavy page from a larger document, likely a guide or manifesto on showrunning.11 laws of showrunning mean version · 11-laws-of-showrunning-mean-version
Deck Investor relations Beat · Need1 hit
08
This appears to be a page from a manuscript or a text-heavy educational deck.11 laws of showrunning mean version · 11-laws-of-showrunning-mean-version
Deck Investor relations Beat · Need1 hit
09
The slide is a polemic against lazy management in television production.11 laws of showrunning mean version · 11-laws-of-showrunning-mean-version
Deck Investor relations Beat · Need1 hit
10
The text discusses the importance of leadership communication and the distinction between superficial perks and genuine employee loyalty.11 laws of showrunning mean version · 11-laws-of-showrunning-mean-version
Deck Investor relations Beat · Need1 hit